Assessing the implementation effectiveness and safety of 1% tenofovir gel provision through family planning services in KwaZulu-Natal, South Africa: study protocol for an open-label randomized controlled trial

BACKGROUND: The Centre for the AIDS Programme of Research in South Africa (CAPRISA) 004 trial demonstrated a 39% reduction in HIV infection, with a 54% HIV reduction in women who used tenofovir gel consistently. A confirmatory trial is expected to report results in early 2015. In the interim, we hav...

詳細記述

保存先:
書誌詳細
出版年:Trials
主要な著者: Mansoor, Leila E, Abdool Karim, Quarraisha, Mngadi, Kathryn T, Dlamini, Sarah, Montague, Carl, Nkomonde, Nelisiwe, Mvandaba, Nomzamo, Baxter, Cheryl, Gengiah, Tanuja N, Samsunder, Natasha, Dawood, Halima, Grobler, Anneke, Frohlich, Janet A, Abdool Karim, Salim S
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2014
主題:
Study Protocol
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4300828/
https://ncbi.nlm.nih.gov/pubmed/25527071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-15-496
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料